Methodology
Executive Summary
In part three of our series, we analyzed the outcomes of terminated deals in terms of the products that advanced in the clinic or went on to be approved post-termination.
You may also be interested in...
Balancing Innovation And Safety – The US and Australian Medtech Regulatory Systems Compared
Effective medical device regulation supports both safety and innovation needs. This article assesses how well the US FDA and the Australian TGA achieve this balance.
GSK Aims To Launch 13 Blockbusters In Five Years
GSK achieved a first-in-class market oncology launch in 2020, but will have to increase that hit rate in order to fulfil its blockbuster ambitions.
Need a specific report? 1000+ reports available
Buy Reports